Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q2 2023 Earnings

Operator: Good day, and thank you for standing by. Welcome to Apellis Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Related Keywords

United States , America , Tazeen Ahmad , Justin Kim , Cedric Francois , Madam Townsend , Yigal Nochomovitz , Laura Chico , Meredith Kaya , Eliana Merle , Caroline Baumal , Colleen Kusy , Steven Seedhouse , Derek Archila , Annabel Samimy , Jonathan Miller , Douglas Tsao , Anupam Rama , Tim Sullivan , Henry Winkler , Raymond James , Phil Nadeau , Wells Fargo , Apellis Pharmaceuticals Inc , Needham Company , Nasdaq , Oppenheimer Company , Welcome To Apellis Pharmaceuticals Second Quarter , Citigroup , Apellis Pharmaceuticals , Call Transcript July , Apellis Pharmaceuticals Second Quarter , Chief Executive Officer , Chief Commercial Officer , Chief Medical Officer , Chief Financial Officer , Umer Raffat , Joseph Stringer ,